New research reveals that GLP-1 drugs like Ozempic may reduce the risk of cancer.
Health FILE - The injectable drug Ozempic is shown Saturday, July 1, 2023, in Houston. Even as millions of older adults clamor for drugs such as Ozempic and Wegovy, monthly use of the medications known as GLP-1 receptor agonists soared nearly 600% between 2020 and 2023 in people under 25 and as young as 12. Researchers found evidence that the use of semaglutide medications, such as Ozempic , helps reduce the risk of obesity-associated cancers in people with Type 2 diabetes.
“We still don’t know how they work. That’s the interesting part,” Abbas said. “What I’ve seen is I’ve seen a lot of maybe sensationalist articles or research studies coming out, you know, some vilify the medication and some kind of like, tell you, this is almost like the next nirvana. I think it’s neither, I think that the area is in the middle, especially for somebody like me who deals with this almost every day.
“There are a few caveats. So, somebody who has a specialty in this, who looks at this paper, they’ve found no difference between the GLP-1s, and metformin, which is a fraction of the price of the GLP-1. So, this paper actually raises more questions,” Abbas said.Researchers studied 13 cancers linked to obesity using the electronic medical data of more than 1.6 million patients.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Beyond Ozempic: New GLP-1 drugs promise weight loss and health benefitsThe World Health Organization issued an alert on falsified versions of Ozempic, the popular drug used to treat type 2 diabetes and obesity. The WHO warned health care professionals and the public to be aware of the counterfeits, which it said are increasing as demand for the drugs grows. NBC News' Anne Thompson reports.
Read more »
Non-Diabetic Use Of GLP-1 Drugs Like Ozempic For Weight Loss Affecting Retail Sizing CurvesI've been a journalist for 30 years, as a senior editor at W magazine, and for the last 17 years, covering retail and real estate as a senior editor at WWD. I write about luxury boutiques, independent retailers, department stores, mass chains, and digitally native brands, and the force that's redefining the way we shop – Amazon.
Read more »
Ozempic and Other GLP-1 Drugs May Cut Cancer RiskNew research suggests GLP-1 drugs like Ozempic can help prevent up to 10 different obesity-related cancers in people with type 2 diabetes.
Read more »
GLP-1 Drugs Ozempic, Wegovy Linked to Rare Blinding ConditionTrendy weight-loss drugs appear to increase the risk of a rare and potentially blinding eye condition, a new study warns.
Read more »
Forget Ozempic and Wegovy — Utahns embracing natural solution to boost GLP-1Given the potential side effects of GLP-1 prescription drugs, many Utahns are seeking alternative methods to naturally boost GLP-1 levels in the body.
Read more »
Ozempic vs Krispy Kreme: Wall Street firm bets weight-loss drugs won’t beat doughnut salesWall Street firm Truist Securities is betting that consumers will still buy Krispy Kreme doughnuts amid the surge in weight-loss drugs like Novo Nordisk's Ozempic.
Read more »